Growth Metrics

Novartis Ag (NVS) Amortization (2020 - 2024)

Novartis Ag's Amortization history spans 5 years, with the latest figure at $1.2 billion for Q4 2024.

  • On a quarterly basis, Amortization rose 7606.67% to $1.2 billion in Q4 2024 year-over-year; TTM through Dec 2024 was $1.2 billion, a 7606.67% increase, with the full-year FY2024 number at $1.2 billion, up 7606.67% from a year prior.
  • Amortization hit $1.2 billion in Q4 2024 for Novartis Ag, up from $419.0 million in the prior quarter.
  • Over the last five years, Amortization for NVS hit a ceiling of $1.2 billion in Q4 2024 and a floor of $15.0 million in Q4 2023.
  • Historically, Amortization has averaged $381.2 million across 4 years, with a median of $218.0 million in 2020.
  • Biggest five-year swings in Amortization: tumbled 55.05% in 2021 and later skyrocketed 7606.67% in 2024.
  • Tracing NVS's Amortization over 4 years: stood at $218.0 million in 2020, then tumbled by 55.05% to $98.0 million in 2021, then plummeted by 84.69% to $15.0 million in 2023, then skyrocketed by 7606.67% to $1.2 billion in 2024.
  • Business Quant data shows Amortization for NVS at $1.2 billion in Q4 2024, $419.0 million in Q2 2024, and $15.0 million in Q4 2023.